Pearl River Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-898
| Closed | -$375K | – | 640 |
|
|
2024
Q1 | $375K | Buy |
+898
| New | +$375K | 0.06% | 345 |
|
|
2023
Q1 | – | Sell |
-8,104
| Closed | -$2.34M | – | 626 |
|
|
2022
Q4 | $2.34M | Buy |
+8,104
| New | +$2.34M | 0.4% | 68 |
|
|
2021
Q4 | – | Sell |
-9,672
| Closed | -$1.75M | – | 583 |
|
|
2021
Q3 | $1.75M | Buy |
+9,672
| New | +$1.75M | 0.48% | 57 |
|
|
2020
Q3 | – | Sell |
-6,671
| Closed | -$1.94M | – | 473 |
|
|
2020
Q2 | $1.94M | Buy |
+6,671
| New | +$1.94M | 0.96% | 26 |
|
|
2020
Q1 | – | Sell |
-1,202
| Closed | -$263K | – | 734 |
|
|
2019
Q4 | $263K | Buy |
+1,202
| New | +$263K | 0.1% | 379 |
|
|
2019
Q2 | – | Sell |
-234
| Closed | -$44K | – | 473 |
|
|
2019
Q1 | $44K | Buy |
+234
| New | +$44K | 0.11% | 250 |
|